Filter
1019
Text search:
Community
Health
Roadmap
Featured
Recommendations
90
New Publications
272
Language
Document type
No document type
458
Studies & Reports
246
Guidelines
119
Strategic & Response Plan
105
Manuals
46
Fact sheets
20
Training Material
12
Situation Updates
6
Online Courses
3
Resource Platforms
2
Brochures
1
Infographics
1
Countries / Regions
Global
60
Sierra Leone
36
Liberia
31
Kenya
30
Africa
30
Western and Central Europe
27
Ethiopia
23
Nigeria
22
India
20
Latin America and the Carribbean
20
Malawi
19
Myanmar / Burma
19
Zambia
17
Tanzania
14
Uganda
13
South Africa
13
West and Central Africa
13
Guinea
12
Ghana
12
Indonesia
12
South–East Asia Region
12
Rwanda
11
East and Southern Africa
11
Eastern Europe
10
Philippines
9
Eastern Europe and Central Asia
8
Congo, Democratic Republic of
7
Nepal
7
Brazil
7
Senegal
6
Haiti
6
Mozambique
6
Middle East and North Africa
6
South Sudan
5
Syria
5
Bangladesh
5
Colombia
5
Asia
5
Central African Republic
4
Namibia
4
Ukraine
4
Lesotho
4
Venezuela
4
Burkina Faso
3
Somalia
3
Pakistan
3
Afghanistan
3
Cambodia
3
Thailand
3
Sudan
3
Eswatini/ Swaziland
3
Botswana
3
Russia
3
Côte d’Ivoire / Ivory Coast
2
Cameroon
2
Zimbabwe
2
Jordan
2
Egypt
2
Ecuador
2
Yemen
2
Laos
2
Moldova
2
Georgia
2
Vietnam
2
Mali
1
USA
1
Iraq
1
Germany
1
Lebanon
1
Turkey
1
Chad
1
China
1
Papua New Guinea
1
Peru
1
North Macedonia
1
Honduras
1
El Salvador
1
Bolivia
1
Angola
1
Madagascar
1
Sri Lanka
1
Chile
1
Western Pacific Region
1
Paraguay
1
Fiji
1
Albania
1
Tajikistan
1
Kazakhstan
1
North America
1
Turkmenistan
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
375
Public Health
70
Clinical Guidelines
65
Women & Child Health
56
Key Resources
43
Capacity Building
13
Pharmacy & Technologies
6
Toolboxes
COVID-19
115
TB
71
NTDs
67
HIV
62
Planetary Health
52
Ebola
49
Mental Health
36
AMR
31
NCDs
31
Rapid Response
21
Conflict
20
Caregiver
20
Global Health Education
17
Cholera
16
Disability
15
Refugee
12
Pharmacy
12
Health Financing Toolbox
12
Polio
9
Natural Hazards
5
Zika
4
Social Ethics
2
Specific Hazards
1
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir
...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
Health Situation
Health policies and systems
Cooperation for Health
WHO Country Cooperation Strategic Agenda (2008-2013)
WHO has a unique combination of technical public health and scientific expertise, and a global operational footprint, with field offices in more than 150 countries. In 2020, this global, technical, and operational reach meant WHO was able to support
...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th
...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
access free courses in more than 60 languages
Known avoidable environmental risks to health cause at least 12.6 million deaths every year, and account for about one quarter of the global burden of disease (2016 data) (1). Air pollution alone causes about 7 million
deaths a year, placing it amo
...
In 2018, the WHO European Healthy Cities Network adopted the political vision of the Network until 2030 that is fully aligned with the United Nations 2030 Agenda for Sustainable Development: the Copenhagen Consensus of Mayors: Healthier and Happier Cities for All. The vision is built around six them
...
first issued 18 August 2022
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic
...
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-
...
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) of antihelmintics is recommended by WHO to elimina
...
International commitment to eliminate trachoma as a public health problem worldwide is supported by resolution WHA51.11 of the World Health Assembly .1 Important progress towards this goal has been
...
SECOND MEETING REPORT
DECATUR, GA, USA, 26 JUNE 2016
Trachoma, caused by particular serovars of Chlamydia trachomatis, is the leading
infectious cause of blindness. Infection is transmitted within ocular and nasal secretions that are passed from person to person on fingers, fomites (such as clothing) and eye-seeking flies (particularly Musca sorbens)
...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, challenges and views on the elimination goal among countries and implementing partners.
3. To assess t
...
Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international
...
